BioWisdom Merges with OmniViz to Expand Informatics Business, Gain US Presence
NEW YORK (GenomeWeb News) – UK-based software firm BioWisdom said today that it has merged with visual informatics provider OmniViz.
OmniViz, a spin-out from Battelle’s Pacific Northwest National Laboratory, provides visual analysis software and services. BioWisdom said that the combined firm will offer software for the "acquisition, integration, visualization, and high-value analysis of healthcare information."
The agreement follows BioWisdom’s acquisition of Lion Biosciences’ bioinformatics business for around $5 million last April.
BioWisdom said that the transaction will also give it a presence in both North America and Europe.
Financial terms of the agreement were not released.
OmniViz’s software is designed to manage large amounts of numeric and categorical data, genome sequences, chemical structures, and text documents. BioWisdom markets its Sofia software suite for healthcare analysis.
OmniViz president Jeff Saffer, who will become president of BioWisdom’s US operations, said the combined informatics technologies "will enable customers to extract greater value from the overwhelming amounts of biomedical information, ultimately leading to improved healthcare."